Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p.Cys1791Tyr) variant

Stem Cell Res. 2023 Apr:68:103050. doi: 10.1016/j.scr.2023.103050. Epub 2023 Feb 15.

Abstract

Marfan syndrome (MFS) is a connective tissue disorder with pleiotropic manifestations in the ocular, skeletal and cardiovascular system. Ruptured aortic aneurysms in MFS patients are associated with high mortality rates. MFS is typically caused by pathogenic variants in the fibrillin-1 (FBN1) gene. Here, we report a generated induced pluripotent cell (iPSC) line of a MFS patient with a FBN1 c.5372G > A (p.Cys1791Tyr) variant. For that, skin fibroblasts of a MFS patient carrying a FBN1 c.5372G > A (p.Cys1791Tyr) variant were successfully reprogrammed into iPSCs using the CytoTune™-iPS 2.0 Sendai Kit (Invitrogen). The iPSCs showed a normal karyotype, expressed pluripotency markers, were able to differentiate into three germ layers and carried the original genotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fibrillin-1 / genetics
  • Genotype
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Marfan Syndrome* / genetics
  • Marfan Syndrome* / pathology
  • Mutation

Substances

  • Fibrillin-1
  • FBN1 protein, human